Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry).

PubWeight™: 3.08‹?› | Rank: Top 1%

🔗 View Article (PMID 16702474)

Published in Circulation on May 15, 2006

Authors

Karim Kalla1, Günter Christ, Ronald Karnik, Reinhard Malzer, Georg Norman, Herbert Prachar, Wolfgang Schreiber, Gerhard Unger, Helmut D Glogar, Alfred Kaff, Anton N Laggner, Gerald Maurer, Johannes Mlczoch, Joerg Slany, Heinrich S Weber, Kurt Huber, Vienna STEMI Registry Group

Author Affiliations

1: Wilhelminenhospital, 3rd Medical Department, Medical University Vienna, Austria.

Articles citing this

Effect of a cognitive aid on adherence to perioperative assessment and management guidelines for the cardiac evaluation of noncardiac surgical patients. Anesthesiology (2014) 3.17

Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J (2009) 2.68

2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management. Heart (2013) 2.18

Reperfusion therapy starts in the ambulance. Circulation (2006) 1.44

Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. CMAJ (2006) 1.27

Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med (2008) 1.20

Acute myocardial infarction system of care in the third world. Neth Heart J (2012) 1.13

STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme. Eur Heart J Acute Cardiovasc Care (2012) 0.93

Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. Vasc Health Risk Manag (2009) 0.91

Timely and optimal treatment of patients with STEMI. Nat Rev Cardiol (2012) 0.89

Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. Eur Heart J (2010) 0.88

Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005-2007. Wien Klin Wochenschr (2010) 0.87

Primary angioplasty for any patient with ST-elevation myocardial infarction? Guideline-adherent feasibility and impact on mortality in a rural infarction network. Clin Res Cardiol (2010) 0.86

Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction. Neth Heart J (2010) 0.85

Do gender differences in primary PCI mortality represent a different adherence to guideline recommended therapy? a multicenter observation. BMC Cardiovasc Disord (2014) 0.83

The management of acute myocardial infarction in the cardiological intensive care units in Italy: the 'BLITZ 4 Qualità' campaign for performance measurement and quality improvement. Eur Heart J Acute Cardiovasc Care (2012) 0.83

Significance of off-hours in centralized primary percutaneous coronary intervention network. Croat Med J (2009) 0.82

Efficacy and limitations of a STEMI network: 3 years of experience within the myocardial infarction network of the region of Augsburg - HERA. Clin Res Cardiol (2013) 0.81

Reperfusion delay in patients treated with primary percutaneous coronary intervention: insight from a real world Danish ST-segment elevation myocardial infarction population in the era of telemedicine. Eur Heart J Acute Cardiovasc Care (2012) 0.81

Organisation of reperfusion therapy for STEMI in a developing country. Open Heart (2015) 0.80

Mortality Trends in Patients Hospitalized with the Initial Acute Myocardial Infarction in a Middle Eastern Country over 20 Years. Cardiol Res Pract (2014) 0.79

Short term cost effectiveness of a regional myocardial infarction network. Health Econ Rev (2013) 0.78

As time goes by?: the fallacy of thrombolysis in STEMI networks. Clin Res Cardiol (2011) 0.78

Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines pertaining to ST-segment-elevation myocardial infarction. Tex Heart Inst J (2008) 0.77

One-year mortality in patients with acute ST-elevation myocardial infarction in the Vienna STEMI registry. Wien Klin Wochenschr (2015) 0.77

Simulation curriculum can improve medical student assessment and management of acute coronary syndrome during a clinical practice exam. Am J Med Sci (2014) 0.75

Ambulance diagnosis of ST elevation myocardial infarction eligible for primary PCI. Neth Heart J (2008) 0.75

The impact of drug eluting stents availability on the treatment choice among medical therapy, percutaneous or surgical revascularisation and on 4-year clinical outcome in patients with coronary artery disease: a cohort study. BMJ Open (2012) 0.75

Reperfusion for STEMI in current Canadian practice: Are we closing the care gap? Mcgill J Med (2011) 0.75

Effectiveness of regionalized systems for stroke and myocardial infarction. Brain Behav (2015) 0.75

Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Crit Care (2016) 0.75

Patient and System-Related Delays of Emergency Medical Services Use in Acute ST-Elevation Myocardial Infarction: Results from the Third Gulf Registry of Acute Coronary Events (Gulf RACE-3Ps). PLoS One (2016) 0.75

Effects of streptokinase on reflow in rescue percutaneous coronary intervention. ARYA Atheroscler (2013) 0.75

Characteristics, treatment and in-hospital outcomes of patients with STEMI in a metropolitan area of a developing country: an initial report of the extended Jakarta Acute Coronary Syndrome registry. BMJ Open (2016) 0.75

Thrombosis - Besieged but Poorly Understood. Front Cardiovasc Med (2014) 0.75

Impact of the Type of First Medical Contact within a Guideline-Conform ST-Elevation Myocardial Infarction Network: A Prospective Observational Registry Study. PLoS One (2016) 0.75

Challenges of STEMI care in India & the real world. Indian Heart J (2015) 0.75

Treatment of acute myocardial infarction: beyond process measures to improve outcome. Wien Klin Wochenschr (2010) 0.75

Articles by these authors

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J (2011) 13.10

Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J (2008) 8.20

Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48

Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med (2013) 6.01

Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med (2014) 5.25

Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49

Guidelines on myocardial revascularization. Eur J Cardiothorac Surg (2010) 3.47

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20

Does carotid stent cell design matter? Stroke (2008) 3.02

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol (2013) 2.90

Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol (2002) 2.88

Bivalirudin started during emergency transport for primary PCI. N Engl J Med (2013) 2.80

Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J (2009) 2.68

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation (2013) 2.64

Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation (2008) 2.59

Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology. EuroIntervention (2013) 2.48

Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging (2013) 2.47

Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation (2006) 2.46

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol (2012) 2.41

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel. Thromb Haemost (2014) 2.29

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. JAMA (2012) 2.22

Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J (2004) 2.11

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J (2014) 2.10

Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation (2013) 2.03

Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation (2004) 2.03

Short versus prolonged bed rest after uncomplicated acute myocardial infarction: a systematic review and meta-analysis. J Clin Epidemiol (2003) 2.01

How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J (2012) 2.00

Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE). J Am Coll Cardiol (2004) 1.98

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol (2009) 1.98

Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J (2010) 1.94

Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation (2005) 1.89

Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J (2010) 1.88

Efficacy and safety of endovascular cooling after cardiac arrest: cohort study and Bayesian approach. Stroke (2006) 1.84

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J (2014) 1.81

Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2011) 1.81

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet (2011) 1.80

Functional MRI of the lung using hyperpolarized 3-helium gas. J Magn Reson Imaging (2004) 1.76

Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest (2013) 1.72

Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation (2009) 1.69

Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg (2007) 1.65

Risk score for peri-interventional complications of carotid artery stenting. Stroke (2006) 1.63

Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Circulation (2012) 1.62

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial. Circulation (2009) 1.60

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol (2014) 1.59

Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion. Thromb Haemost (2010) 1.58

Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med (2006) 1.58

Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation (2004) 1.56

Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals. Stroke (2002) 1.55

The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial. J Am Coll Cardiol (2003) 1.54

Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit Care Med (2002) 1.53

Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Heart (2010) 1.53

Vascular dysfunction after coarctation repair is related to the age at surgery. Int J Cardiol (2005) 1.53

Non-conventional markers of atherosclerosis before and after gastric banding surgery. Eur Heart J (2009) 1.53

Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. Stroke (2013) 1.53

[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ (2012) 1.51

Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model. Stroke (2004) 1.51

A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure. Int J Cardiol (2012) 1.51

Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart (2010) 1.50

Systemic pressure does not directly affect pressure gradient and valve area estimates in aortic stenosis in vitro. Eur Heart J (2008) 1.49

A mimic of sarcoidosis. Lancet (2007) 1.49

Hemostasis in cardiac arrest patients treated with mild hypothermia initiated by cold fluids. Resuscitation (2009) 1.49

Extracorporeal venovenous cooling for induction of mild hypothermia in human-sized swine. Crit Care Med (2005) 1.48

Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels. Crit Care Med (2009) 1.48

Cold aortic flush and chest compressions enable good neurologic outcome after 15 mins of ventricular fibrillation in cardiac arrest in pigs. Crit Care Med (2010) 1.48

Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study. Eur Heart J (2004) 1.48

2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study. JACC Cardiovasc Interv (2009) 1.48

Outcome of combined stenotic and regurgitant aortic valve disease. J Am Coll Cardiol (2013) 1.47

The role of European national journals in education. Heart (2009) 1.46

Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol (2002) 1.46

Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J (2013) 1.46

The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg (2004) 1.45

Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J Am Coll Cardiol (2004) 1.45

The honey man--second degree heart block after honey intoxication. Int J Cardiol (2008) 1.43

Effect of rest on physicians' performance in an emergency department, objectified by electroencephalographic analyses and psychometric tests. Crit Care Med (2002) 1.43

Serial lactate determinations for prediction of outcome after cardiac arrest. Medicine (Baltimore) (2004) 1.42

Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J (2011) 1.42

Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor. Thromb Res (2004) 1.39

Endothelin-1 elevates regional cerebral perfusion during prolonged ventricular fibrillation cardiac arrest in pigs. Resuscitation (2002) 1.39

Hypokalemic paralysis in a professional bodybuilder. Am J Emerg Med (2011) 1.39

Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res (2015) 1.39

Ramipril prior to thrombolysis attenuates the early increase of PAI-1 in patients with acute myocardial infarction. Thromb Haemost (2002) 1.38

The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination. JACC Cardiovasc Interv (2011) 1.38

Safety, feasibility, and hemodynamic and blood flow effects of active compression-decompression of thorax and abdomen in patients with cardiac arrest. Crit Care Med (2008) 1.38

History of previous bleeding and C-reactive protein improve assessment of bleeding risk in elderly patients (≥ 80 years) with myocardial infarction. Thromb Haemost (2015) 1.38

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 1.36

Cold infusions alone are effective for induction of therapeutic hypothermia but do not keep patients cool after cardiac arrest. Resuscitation (2007) 1.35

Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost (2011) 1.35